Lucid Diagnostics Inc reports results for the quarter ended in June - Earnings Summary

Lucid Diagnostics

12/08/2024 17:03

* Lucid Diagnostics Inc  LUCD.OQ  reported a quarterly
adjusted
loss of 23 cents​​ per share for the quarter ended in June,
identical to the same quarter last year.  The mean expectation
of six analysts for the quarter was for a loss of 22 cents per
share. Wall Street expected results to range from -24 cents
to -20 cents per share.
    * Revenue rose 513.8% to $976.00 thousand from a year ago;
analysts expected $1.23 million. 
    * Lucid Diagnostics Inc's reported EPS for the quarter was a
loss
of 23 cents​.
    * The company reported a quarterly loss of $11.01 million.
    * Lucid Diagnostics Inc shares had fallen by 3.7% this
quarter and
lost 44.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 6.8%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Lucid Diagnostics
Inc is $3.00 
This summary was machine generated from LSEG data August 12 at
04:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.22          -0.23          Missed
 Mar. 31 2024      -0.27          -0.40          Missed
 Dec. 31 2023      -0.26          -0.25          Beat
 Sep. 30 2023      -0.27          -0.34          Missed